Litcius/Paper detail

The arsenal of TP53 mutants therapies: neoantigens and bispecific antibodies

Chang Yang, Ge Lou, Weilin Jin

2021Signal Transduction and Targeted Therapy14 citationsDOIOpen Access PDF

Topics & Concepts

Bispecific antibodyAntibodyMedicineImmunologyVirologyMonoclonal antibodyCAR-T cell therapy researchMonoclonal and Polyclonal Antibodies ResearchChronic Lymphocytic Leukemia Research
The arsenal of TP53 mutants therapies: neoantigens and bispecific antibodies | Litcius